Injection Of Agent Research Articles

COMPARISON OF THE EFFICACY OF ARTHROCENTESIS WITH AND WITHOUT CONCENTRATED GROWTH FACTOR INJECTIONS IN REDUCING CLINICAL SYMPTOMS IN PATIENTS WITH TEMPOROMANDIBULAR JOINT OSTEOARTHRITIS

There is a significant prevalence of temporomandibular joint (TMJ) disorders, estimated at 34% according to various sources. Given that this condition often leads to a reduced quality of life and disability, there is a pressing need to develop and implement effective treatment methods. Arthrocentesis, along with the injection of pharmacological agents—particularly platelet-rich plasma—into the joint cavity, is a recognized treatment for TMJ osteoarthritis. Recently, a third generation of platelet concentrates has been developed, which is an evolutionary advancement of the platelet-rich plasma technique. This study involved 60 patients, equally divided into control and experimental groups. The control group was treated with arthrocentesis for TMJ osteoarthritis, while the experimental group received arthrocentesis combined with intra-articular injections of concentrated growth factor. The effectiveness of the treatments was evaluated using the visual analogue scale (VAS) for pain and measuring maximum mouth opening. The study results showed a 74.22% reduction in VAS scores in the control group and a 79.87% reduction in the experimental group (p < 0.001). Maximum mouth opening increased by 17.84% in the control group and by 20.53% in the experimental group (p < 0.001). Both treatment methods demonstrated significant clinical efficacy (p < 0.001). In our opinion, the use of arthrocentesis with concentrated growth factor injections for the treatment of TMJ osteoarthritis is clinically justified and more effective than arthrocentesis alone.

High‐resolution perfusion imaging in rodents using pCASL at 9.4 T

AbstractAdequate perfusion is critical for maintaining normal brain function and aberrations thereof are hallmarks of many diseases. Pseudo‐Continuous Arterial Spin Labeling (pCASL) MRI enables noninvasive quantitative perfusion mapping without contrast agent injection and with a higher signal‐to‐noise ratio (SNR) than alternative methods. Despite its great potential, pCASL remains challenging, unstable, and relatively low‐resolution in rodents – especially in mice – thereby limiting the investigation of perfusion properties in many transgenic or other relevant rodent models of disease. Here, we address this gap by developing a novel experimental setup for high‐resolution pCASL imaging in mice and combining it with the enhanced SNR of cryogenic probes. We show that our new experimental setup allows for optimal positioning of the carotids within the cryogenic coil, rendering labeling reproducible. With the proposed methodology, we managed to increase the spatial resolution of pCASL perfusion images by a factor of 15 in mice; a factor of 6 in rats is gained compared to the state of the art just by virtue of the cryogenic coil. We also show that the improved pCASL perfusion imaging allows much better delineation of specific brain areas, both in healthy animals as well as in rat and mouse models of stroke. Our results bode well for future high‐definition pCASL perfusion imaging in rodents.

Second generation multiple channeling using platelet-rich plasma enhances cartilage repair through recruitment of endogenous MSCs in bone marrow.

In the treatment of cartilage defects, a key factor is the adequate and specific recruitment of endogenous stem cells to the site of injury. However, the limited quantity and capability of endogenous bone marrow stem cells (BM MSCs) often result in the formation of fibrocartilage when using bone marrow stimulation (BMS) procedures. We engineered second-generation platelet-rich plasma (2G PRP) with defibrinogenating and antifibrinolytic agents for injection into the condyle of the right femur, followed by multiple channeling (MCh) 5 days later. This approach aims to enhance repair by promoting the local proliferation and migration of BM MSCs to the full-thickness knee cartilage defect (ftKD). In our in vitro study, 2G PRP increased the number of endogenous BM MSCs and their ability to migrate toward an IL-1β-induced inflammatory condition. This significance was further confirmed by in vivo proliferation results after injection of 2G PRP into the condyle of rats. Fifty-four healthy male Sprague-Dawley rats were divided into 3 groups (ftKD, MCh, 2G MCh) for 3 time points (2 weeks, 4 weeks, 8 weeks). The 2G MCh (2G PRP injection + MCh) groups significantly improved cartilage formation at 4 and 8 weeks compared to the ftKD and MCh groups. The 2G MCh initiated cartilage repair earlier than MCh and significantly enhanced up to 8 weeks. This study demonstrated that 2G PRP increased the number of BM MSCs through the enhancement of proliferation and recruitment into the injured site, thereby improving articular cartilage repair.

Study on the Migration Mechanism of Temporary Plugging Agent in Artificial Fractures of Deep Geothermal Reservoirs Based on the Euler-Euler Multiphase Flow Model

The successful use of temporary plugging diverting fracturing technology requires an understanding of the migration and plugging processes of temporary plugging agents into artificial fractures under high temperature settings. In this study, a multiphase flow model for the migration of temporary plugging agents in artificial fractures was developed using the Euler-Euler framework, and numerical simulations were conducted at elevated temperatures. Various factors, including plugging agent injection velocity, concentration, carrying fluid viscosity, wall temperature, and fracture width, were systematically analyzed to assess their impact on the agent’s migration behavior. Detailed analyses, using cloud diagrams of particle volume fraction, velocity, and turbulence intensity, clarified the underlying mechanisms influencing the migration process. The results indicate that as the injection velocity increases, the height of blockages near the wellbore decreases, while the blockage length initially increases before declining. Increasing the concentration of the plugging agent leads to a rise in blockage height and a shift in the front edge toward the injection point. Enhancing the viscosity of the carrying fluid enables the plugging agent to migrate deeper into the fracture, improving deep plugging effectiveness. While changes in wall temperature have limited impact on blockage morphology, temperatures exceeding the critical threshold of 573K significantly intensify particle migration. Moreover, increasing fracture width enhances both the height and length of blockages, with the optimal plugging effect observed when the plugging agent diameter is approximately one-third of the fracture width.

Saturation transfer (CEST and MT) MRI for characterization of U-87 MG glioma in the rat.

The focus of this work was to identify the optimal magnetic resonance imaging (MRI) contrast between orthotopic U-87 MG tumours and normal appearing brain with the eventual goal of treatment response monitoring. U-87 MG human glioblastoma cells were injected into the brain of RNU nude rats (n= 9). The rats were imaged at 7T at three timepoints for all animals: 3-5, 7-9, and 11-13 days after implantation. Whole-brain T1-weighted (before and after gadolinium contrast agent injection), diffusion, and fluid-attenuated inversion recovery scans were performed. In addition, single-slice saturation-transfer-weighted chemical exchange saturation transfer (CEST), magnetization transfer (MT), and water saturation shift referencing (WASSR) contrast Z-spectra and T1 and T2 maps were also acquired. The MT and WASSR Z-spectra and T1 map were fitted to a two-pool quantitative MT model to estimate the T2 of the free and macromolecular-bound water molecules, the relative macromolecular pool size (M0, MT), and the magnetization exchange rate from the macromolecular pool to the free pool (RMT). The T1-corrected apparent exchange-dependent relaxation (AREX) metric to isolate the CEST contributions was also calculated. The lesion on M0, MT and AREX maps with a B1 of 2μT best matched the hyperintensity on the post-contrast T1-weighted image. There was also good separation in Z-spectra between the lesion and contralateral cortex in the 2-μT CEST and 3- and 5-μT MT Z-spectra at all time points. A pairwise Wilcoxon signed-rank tests with Holm-Bonferroni adjustment on MRI parameters was performed and the differences between enhancing lesion and contralateral cortex for the MT ratio with 2μT saturation at 3.6ppm frequency offset (corresponding to the amide chemical group) and M0, MT were both strongly significant (p< 0.001) at all time points. This work has identified that differences between enhancing lesion and contralateral cortex are strongest in MTR with B1=2μT at 3.6ppm and relative macromolecular pool size (M0, MT) images over entire period of 3-13 days after cancer cell implantation.

Optimization of image shoot timing for cerebral veins 3D-digital subtraction angiography by interventional angiography systems

Abstract3D-digital subtraction angiography (3D-DSA) is essential for understanding the anatomical structure of cerebral veins, crucial in brain tumor surgery. 3D-DSA produces three-dimensional images of veins by adjusting the X-ray delay time after contrast agent injection, but the delineation of veins varies with the delay in X-ray timing. Our study aimed to refine the delay time using time-enhancement curve (TEC) analysis from 2D-DSA conducted before 3D-DSA imaging. We retrospectively reviewed 26 meningioma patients who underwent cerebral angiography from March 2020 to August 2021. Using 2D-DSA, we analyzed arterial and venous TECs to determine the contrast agent’s peak time and estimated the optimal imaging timing. Cases performed near this optimal time were in Group A, and others in Group B, with cerebral venous pixel values compared between them. TEC analysis identified peak times: internal carotid artery: 2.8 ± 0.7 s, middle cerebral artery (M4): 4.1 ± 0.9 s, superior sagittal sinus: 8.3 ± 1.1 s, sigmoid sinus: 9.5 ± 1.3 s, and venous structures near tumors: 7.3 ± 1.0 s. We observed several veins peaking immediately after arterial contrast passage, suggesting the optimal X-ray delay should incorporate the arterial contrast agent’s transit time. Statistical analysis revealed that Group A, with imaging timed to reflect the contrast agent transit time, demonstrated significantly better contrast effects than Group B. The X-ray delay time for 3D-DSA imaging of cerebral veins can be optimized in angiography systems by incorporating the contrast agent transit time, calculated from TEC analysis of cerebral 2D-DSA images.

Effects of water injection on reaction temperature and hydrogen production in horizontal co-axial underground coal gasification

Underground coal gasification (UCG) is process of directly recovering energy as combustible gases such as hydrogen and carbon monoxide by combusting unmined coal resources in situ. During UCG process, the temperature in the gasification zone can exceed 1,300 °C, raising concerns about the potential melting of the steel pipe for oxidant injection. To control the temperature in the gasification zone, the use of water injection as an injection agent can be an option. Injecting water during UCG process serves two purposes: it decreases the temperature in the reaction zone by the endothermic effect of water, and it enhances the production of H2 by the reduction reaction of water. However, injecting excessive amounts of water may lead to a significant decrease in the temperature in the reaction zone, consequently cannot maintain the temperature range required for the UCG reaction. This study discusses the effects of water injection on the temperature of the gasification zone and the product gas by developing a chemical reaction model of UCG using COMSOL Multiphysics® software. The model was developed based on the temperature and produced gas results obtained from laboratory-scale artificial coal seam UCG experiments. Our findings reveal that water injection significantly influences the gasification process, controlling temperature in the reaction zone and promoting H2 production through steam gasification and water-gas shift reactions. Moreover, under the experiment and analysis conditions of this study, it is revealed that water injection up to an H2O/O2 molar ratio of 3.9 can effectively control the temperature of the gasification zone with enhancing H2 production.

Microfluidic-Generated Injectable Bulking Agents with Biocompatible Surfaces and Their Mid-term Outcomes in a Rat Model with Anal Sphincter Injury.

Bulking agents have gained attention as new, minimally invasive treatments for fecal incontinence. Various materials and surface treatment techniques have been extensively studied to ensure good biocompatibility and long-term stability. Despite significant improvements in biocompatibility, the nonuniform particle size of existing materials has led to other challenges, such as the induction of phagocytosis or reduction of injectability during in vivo tests. This study aimed to conduct a preclinical test of the midterm stability of bulking agents with newly formulated particles with uniform size. To this end, the particles were fabricated using microfluidics, resulting in a narrow size dispersity of less than 5% as the coefficient of variation, which is essentially distinct from conventional bulking agents. The microfluidic fabrication resulted in uniformly sized particles larger than the in vivo migratory limit of 80 μm and in a reduction in maximum injection pressure. Histological staining and microscopic observations confirmed proper positioning of the filler materials in vivo and a negligible immune response for up to 6 months, indicating successful midterm stability.

Carbon dioxide injection into the Achimov formations using reinjection technology by the example of Ach3-4 formation in the Novo-Urengoy area of the Urengoy field

The prerequisites for the study are the calculation results for the cycling process, where carbon dioxide is proposed as the injection agent into the Achimov formations instead of dry gas, with the goal of increasing the condensate recovery factor. The work is focused on the efficiency assessment of carbon dioxide reinjection technology and reducing carbon footprint at a late stage of field development. The research object is the Аch3-4 formation within the Novo-Urengoy license area of the Urengoy field. The leading method to identify this problem is the results of the full-scale composite dynamic model in the ECLIPSE 300 format. The model takes into account the history of field development on depletion. The articles deals with two schemes for injecting carbon dioxide into the formation. In the first scheme, pure carbon dioxide is injected in a closed-loop system, but carbon neutrality through storage is not achieved. In the second scheme, carbon dioxide is injected using reinjection technology. Once injection begins, gas production stops. Only the condensate separated from the formation gas during low-temperature separation is sold and sent for further processing. After allocation of the condensate, the mixture of natural gas and carbon dioxide, in a specific proportion, is sent to the compressor station for reinjection into the formation in a gaseous state. Injecting pure carbon dioxide achieves a condensate recovery factor similar to that of gas injection with a 30 % carbon dioxide mixture. However, this option is less economically viable compared to the base and other scenarios due to high capital costs for upgrading the existing gas processing equipment (requiring the construction of an amine treatment unit). With carbon dioxide injection using reinjection technology, in addition to recovering extra condensate that had condensed during natural depletion, a reduction in the carbon footprint is also achieved. To maximize the condensate recovery factor, the optimal concentration of carbon dioxide in the injection mixture has been determined. The optimal timing for the start of injection was identified to maximize gas recovery. Economic efficiency is expected from the additional recovery of condensate trapped in the reservoir and from achieving carbon neutrality through the monetization and storage of carbon dioxide.

Optimized emamectin benzoate trunk injection: addressing temperature limitations for pine wilt disease control.

Pine wilt disease (PWD), caused by the pinewood nematode Bursaphelenchus xylophilus, poses a significant threat to global forestry, resulting in extensive economic and ecological damage. Traditional trunk injection agents (TIAs) are limited by environmental factors, such as high winter temperatures and vigorous resin flow, particularly in southern China. This study aimed to develop an ordinary temperature trunk injection agent (OTTIA) for year-round application and to evaluate its performance under high-temperature conditions in comparison to commercial TIAs. Extensive laboratory and field tests identified N,N-Dimethylformamide (DMF) and benzyl acetate as optimal solvents and Tween-40 as an effective emulsifier for the OTTIA formulation. The new agent was fully absorbed by Pinus massoniana within 3 h at temperatures exceeding 30 °C, outperforming existing commercial agents. Treated trees maintained comparable emamectin benzoate (EB) levels but achieved lower LC90 lethal concentration values (27.65 mg L-1), indicating greater efficacy. The OTTIA provided protection against PWD for ≤360 days postinjection. The development of OTTIA marks a significant advancement in PWD management, offering an effective solution for high-temperature regions and potentially transforming year-round treatment strategies. The results highlight the critical role of optimizing solvent and emulsifier combinations to enhance the efficacy and application of trunk injection agents, contributing to sustainable forest management and improved protection against PWD. © 2024 Society of Chemical Industry.

Expanding Treatment Opportunities: Reviewing the Current State of Injectable Antiretrovirals for Treatment of HIV.

Antiretroviral therapy has evolved significantly over the last 20-30years, from requiring multiple tablets multiple times per day to single-tablet regimens and most recently, in 2021, long-acting injectable antiretrovirals. These long-acting antiretrovirals have expanded the treatment options for individuals with HIV who may have difficulty adhering to daily oral medications, difficulty taking oral medications, and/or individuals with multidrug-resistant HIV. This article reviews the currently available long-acting injectable antiretrovirals, including cabotegravir/rilpivirine, lenacapavir, and ibalizumab. The available data supporting these agents and current place in therapy will be discussed. Data supporting the use of additional long-acting injectable agents, broadly neutralizing antibodies, currently in the pipeline will be reviewed as well.

New calcimimetics for secondary hyperparathyroidism in CKD G5D: do they offer advantages?

Secondary hyperparathyroidism is one of the most frequent metabolic abnormalities found in patients with chronic kidney disease. The calcium-sensing receptor senses extracellular calcium and is the principal regulator of parathyroid hormone secretion. Cloning of the calcium-sensing receptor led to the development of calcimimetics, drugs that decrease parathyroid hormone secretion through the positive allosteric modulation of this receptor. Cinacalcet was the first oral calcimimetic approved by the US Food and Drug Administration (FDA) in 2004 for the treatment of secondary hyperparathyroidism in adult patients on dialysis. Although cinacalcet has demonstrated safety and effectiveness, it has two main problems: gastrointestinal side effects that result in poor adherence, and the inhibitory action on CYP2D6 with the possibility of interactions with commonly used medications. To address the problem of oral compliance, Etelcalcetide, a small synthetic polycationic peptide IV calcimimetic was introduced in 2017. This drug showed a 10% greater decrease in serum parathyroid hormone values compared to cinacalcet but no better gastrointestinal tolerance, with greater risk of hypocalcemia. Several structural modifications were introduced in cinacalcet to produce a new compound called evocalcet. This drug, which was introduced in Japan in 2018, has considerably enhanced bioavailability and decreased both the inhibitory effect on CYP2D6 and half of the gastrointestinal side effects of cinacalcet. Finally, a novel non-peptidic injectable calcimimetic agent, upacicalcet, became available in Japan in 2021. This agent has greater clearance by hemodialysis and shows no effect on gastric emptying. More studies are needed comparing the old calcimimetics to the new ones to establish their future role in the treatment of secondary hyperparathyroidism in chronic kidney disease (CKD) G5D.

Serial intravitreal injections in age-related macular degeneration patients from the dry eye disease perspective: a cross-sectional study

BackgroundTo evaluate the effects of serial intravitreal injections (IVI) on the ocular surface and meibomian glands in patients with neovascular age-related macular degeneration (nAMD).MethodsPatients receiving anti-vascular endothelial growth factor (anti-VEGF) agent injections for unilateral nAMD were included. Untreated fellow eyes served as the control group. All participants followed a pre-IVI asepsis protocol with povidone-iodine (PI). Ocular surface diseases index (OSDI) questionnaire scores, first and average non-invasive tear break-up time (fNITBUT and avgNITBUT), Schirmer-1 test results, corneal staining score (according to Oxford scale), meibomian gland (MG) loss rates of lower and upper eyelids were recorded four weeks after the last IVI.ResultsForty-two nAMD patients with a mean age of 63.3 ± 19.4 were included in the study. The mean OSDI score was 20.3 and the median of IVI number was 9 (6–22). There were no statistically significant difference between treated and untreated fellow eyes regarding fNITBUT (5.6 vs. 4.5, p = 0.872), avgNITBUT (6.2 vs. 7.2, p = 0.968), Shirmer-1 results (7 vs. 7, p = 0.854), corneal staining (0.3 vs. 0.2, p = 0.341), lower and upper MG loss rate (29.3 vs. 28.4, p = 0.162, and 27.1 vs. 26.9, p = 0.476, respectively). Only significant correlation was observed between age with lower and upper MG loss rate (r:0.396, p = 0.042, and r:0.365, p = 0.047).ConclusionThe results of the present study demonstrated that serial IVI of anti-VEGF agents with PI asepsis is well tolerated by nAMD patients in terms of ocular surface, MG loss and DED measurements.

Free-breathing 3D cardiac extracellular volume (ECV) mapping using a linear tangent space alignment (LTSA) model.

To develop a new method for free-breathing 3D extracellular volume (ECV) mapping of the whole heart at 3 T. A free-breathing 3D cardiac ECV mapping method was developed at 3 T. T1 mapping was performed before and after contrast agent injection using a free-breathing electrocardiogram-gated inversion recovery sequence with spoiled gradient echo readout. A linear tangent space alignment model-based method was used to reconstruct high-frame-rate dynamic images from (k,t)-space data sparsely sampled along a random stack-of-stars trajectory. Joint T1 and transmit B1 estimation were performed voxel-by-voxel for pre- and post-contrast T1 mapping. To account for the time-varying T1 after contrast agent injection, a linearly time-varying T1 model was introduced for post-contrast T1 mapping. ECV maps were generated by aligning pre- and post-contrast T1 maps through affine transformation. The feasibility of the proposed method was demonstrated using in vivo studies with six healthy volunteers at 3 T. We obtained 3D ECV maps at a spatial resolution of 1.9 × 1.9 × 4.5 mm3 and a FOV of 308 × 308 × 144 mm3, with a scan time of 10.1 ± 1.4 and 10.6 ± 1.6 min before and after contrast agent injection, respectively. The ECV maps and the pre- and post-contrast T1 maps obtained by the proposed method were in good agreement with the 2D MOLLI method both qualitatively and quantitatively. The proposed method allows for free-breathing 3D ECV mapping of the whole heart within a practically feasible imaging time. The estimated ECV values from the proposed method were comparable to those from the existing method.

Wood fibers with natural blowing agents for extrusion and injection molding of polypropylene

ABSTRACT This paper presents a new two-step approach of foaming polypropylene (PP) containing wood fibers (WF) with tri-sodium citrate dihydrate as the low-temperature chemical blowing agent (CBA) and sucrose as the high-temperature CBA. The first CBA was intentionally selected to thermally degrade during extrusion (lower temperature range), whereas the second CBA during the injection molding (higher temperature range). The CBAs were dissolved in water, and WF were soaked in these solutions, afterward dried, ground, and then mixed with PP and extruded. The extruded granules were then injection molded to produce dumbbell-shaped samples. The porosity, thermal degradation, PP crystallization, mechanical and thermomechanical properties of the wood-polymer composites (WPCs), as well as their susceptibility to acoustic damping, were determined. It was shown that sucrose can be an effective CBA for injection-molded WPC samples. However, the effectiveness of this additive is improved by the addition of tri-sodium citrate dihydrate, which decomposed during extrusion.

Self-gated free-running 5D whole-heart MRI using blind source separation for automated cardiac motion extraction.

To compare two blind source separation (BSS) techniques to principal component analysis and the electrocardiogram for the identification of cardiac triggers in self-gated free-running 5D whole-heart MRI. To ascertain the precision and robustness of the techniques, they were compared in three different noise and contrast regimes. The repeated superior-inferior (SI) projections of a 3D radial trajectory were used to extract the physiological signals in three cardiac MRI cohorts: (1) 9 healthy volunteers without contrast agent injection at 1.5T, (2) 30 ferumoxytol-injected congenital heart disease patients at 1.5T, and (3) 12 gadobutrol-injected patients with suspected coronary artery disease at 3T. Self-gated cardiac triggers were extracted with the three algorithms (principal component analysis [PCA], second-order blind identification [SOBI], and independent component analysis [ICA]) and the difference with the electrocardiogram triggers was calculated. PCA and SOBI triggers were retained for image reconstruction. The image sharpness was ascertained on whole-heart 5D images obtained with PCA and SOBI and compared among the three cohorts. SOBI resulted in smaller trigger differences in Cohorts 1 and 3 compared to PCA (p < 0.01) and in all cohorts compared to ICA (p < 0.04). In Cohorts 1 and 3, the sharpness increased significantly in the reconstructed images when using SOBI instead of PCA (p < 0.03), but not in Cohort 2 (p = 0.4). We have shown that SOBI results in more precisely extracted self-gated triggers than PCA and ICA. The validation across three diverse cohorts demonstrates the robustness of the method against acquisition variability.

Modeling and Visualization of Coolant Flow in a Fuel Rod Bundle of a Small Modular Reactor

This article presents the results of an experimental study of the coolant flow in a fuel rod bundle of a nuclear reactor fuel assembly of a small modular reactor for a small ground-based nuclear power plant. The aim of the work is to experimentally determine the hydrodynamic characteristics of the coolant flow in a fuel rod bundle of a fuel assembly. For this purpose, experimental studies were conducted in an aerodynamic model that included simulators of fuel elements, burnable absorber rods, spacer grids, a central displacer, and stiffening corners. During the experiments, the water coolant flow was modeled using airflow based on the theory of hydrodynamic similarity. The studies were conducted using the pneumometric method and the contrast agent injection method. The flow structure was visualized by contour plots of axial and tangential velocity, as well as the distribution of the contrast agent. During the experiments, the features of the axial flow were identified, and the structure of the cross-flows of the coolant was determined. The database obtained during the experiments can be used to validate CFD programs, refine the methods of thermal-hydraulic calculation of nuclear reactor cores, and also to justify the design of fuel assemblies.

A Brief Review on Adult-Onset Coats' Disease.

Adult-onset Coats disease is an uncommon and vision-threatening disease characterized by the development of abnormal blood vessels in the retina. Coats' disease commonly affects children in the first decade of life, but very rarely manifests in adults after the third decade of life, or who characteristically present with unilateral vision loss. Despite being a sight-threatening disease, the etiology remains inconclusive and various genetic and vascular abnormalities are implicated. Diagnosis relies on ophthalmologic examination, fundus photography, fluorescein angiography, and optical coherence tomography. Treatment modalities include laser photocoagulation, intravitreal injections of anti-vascular endothelial growth factor agents, and, in advanced cases, surgical interventions are needed and the treatment is aimed at avoiding complications like retinal detachment and neovascular glaucoma, which were comparatively rare in adult-onset Coats' disease. Despite therapeutic advancements, the prognosis varies, with some patients experiencing significant visual impairment. This review outlines the clinical features, diagnosis, management, and prognosis of adult-onset Coats' disease, underscoring the importance of early detection and intervention in optimizing visual outcomes.

Cervical Cytological and Colposcopic Findings in Cases Associated with Prolonged Use of Intrauterine Devices versus Long Acting Injectable Contraceptive Agents

Cervical Cytological and Colposcopic Findings in Cases Associated with Prolonged Use of Intrauterine Devices versus Long Acting Injectable Contraceptive Agents

Isolation and focal treatment of brain aneurysms using interfacial fluid trapping.

Current approaches for localized intravascular treatments rely on using solid implants, such as metallic coils for embolizing aneurysms, or on direct injection of a therapeutic agent that can disperse from the required site of action. Here, we present a fluid-based strategy for localizing intravascular therapeutics that leverages surface tension and immiscible fluid interactions, to allow confined and focal treatment at brain aneurysm sites. We first show, computationally and experimentally, that an immiscible phase can be robustly positioned at the neck of human aneurysm models to seal and isolate the aneurysm's cavity for further treatment, including in wide-neck aneurysms. We then demonstrate localized delivery and confined treatment, by selective staining of cell nuclei within the aneurysm cavity as well as by hydrogel-based embolization in patient-specific aneurysm models. Altogether, our interfacial flow-driven strategy offers a potential approach for intravascular localized treatment of cardiovascular and other diseases.